Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 3, 2000

View Archived Issues

Cerus continues phase III trial of platelet pathogen inactivation system in Europe

Two additional U.S. patents allowed for Maxamine technology

NPS Allelix drug candidate enhances bone growth in space shuttle experiments

Arena and Fujisawa establish collaboration in neurodegenerative disease area

Cambridge Drug Discovery and Parke-Davis complete screening collaboration

IND filed for nasal leuprolide as endometriosis therapy

Telik initiates clinical testing of first development candidate

Novel agent for treatment-refractory CIS now under review in Canada

Idun and Elan establish stroke therapy collaboration

Novel isatin derivatives with broad-spectrum antibacterial and antifungal activity

Alexion to commence development of 5G1.1 for treatment of dermatomyositis

Elan establishes new agreement with Wyeth-Ayerst for integrin inhibitors

Combidex contrast agent receives priority review status from FDA

Focus on carbapenem modifications continues at Merck

Emtricitabine-containing HAART regimen is highly efficacious in French study

Potent, broad-spectrum cephalosporins in development at Roche

Preliminary results in volunteers reinforce the promise of DuPont's second-generation NNRTIs

Incyte patents novel GFMOs for cancer and fibrotic disorders

Boston Life Sciences identifies target of CNS growth factor products

Novel 5-HT7 antagonists for CNS disorders under investigation at DuPont

Lilly describes 5-HT1F agonists as potential antimigraine agents

Aventis Behring launched

Lilly assesses potential utility of PLA2 inhibitors for septic shock

Roxane launches orphan drug for treatment of apnea in premature infants

BMS informs of first launch for new quinolone

Pliva presents new azithromycin derivatives at ICMASKO 5

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...